Bloomberg Law
Free Newsletter Sign Up
Bloomberg Law
Free Newsletter Sign Up

Ark Funds Sells Huya, Novartis; Buys UiPath, Recursion (Correct)

July 10, 2021, 4:56 AM

Exchange-traded funds managed by Cathie Wood’s Ark Investment Management sold about 273,735 American depository receipts of Huya Inc., according to a trading update.

China’s antitrust regulators on Saturday rejected Huya’s proposal to merge with DouYu International Holdings Ltd, saying that it would give Tencent Holdings Ltd. -- which owns stakes in both companies -- an unfair advantage in the country’s game streaming market.

Read: China Watchdog Rejects Tencent-Led Game Streaming Deal

Ark funds also sold 71,238 Novartis AG ADRs, while they bought 247,130 UiPath Inc. shares, 65,737 Recursion Pharmaceuticals Inc. and 58,914 Signify Health Inc. shares.

NOTE: Ark’s ...

To read the full article log in.

Learn more about a Bloomberg Law subscription.